Kim Emily Y, Patel Ursula, Patel Bhairvi, Suda Katie J
Edward Hines, Jr. VA Hospital, Hines, IL, USA.
University of Illinois at Chicago, IL, USA.
J Pharm Technol. 2017 Oct;33(5):183-188. doi: 10.1177/8755122517718214. Epub 2017 Jul 14.
This study aims to evaluate the treatment and follow-up of bacteriuria in the emergency department (ED). The primary objective was to determine the frequency of patients discharged from the ED with antibiotics for symptomatic and asymptomatic bacteriuria, and the secondary objectives were to determine the frequency of patients receiving postdischarge antibiotic interventions and antibiotic-related adverse drug reactions (ADRs). This retrospective study evaluated patients with ED urine cultures sent between October 1, 2015, and November 24, 2015. Patients with indwelling catheters, concurrent antibiotics, and admission for inpatient care were excluded. tests and contingency tables were applied in SAS; < .05 was considered significant. Of 429 unique patients with urine cultures drawn in the ED, 13.1% (n = 56) received treatment for a bacteriuria. The majority of patients discharged from the ED with antibiotics had urinary tract infection (UTI) symptoms documented in the medical record (76.8%; n = 43). Of those patients who required postdischarge interventions, 4 out of 13 had appropriate antibiotic adjustments based on culture and sensitivity results at follow-up. In a subset of patients with inappropriately ordered urine cultures (no UTI symptoms documented or antibiotic prescribed), a higher percentage of patients had normal urinalyses (UA) compared to abnormal UAs (83.3% vs 10.4%, = .0008). No significant ADRs were identified. The majority of patients treated for bacteriuria in the ED had documented symptoms consistent with UTIs and appropriate empiric antibiotics. However, incorporating antimicrobial stewardship activities in the ED targeting unnecessary urine cultures and assuring postdischarge follow-up if treatment modification is needed based on culture results can improve antibiotic prescribing.
本研究旨在评估急诊科(ED)对菌尿症的治疗及随访情况。主要目标是确定因有症状和无症状菌尿症而在急诊科出院时接受抗生素治疗的患者频率,次要目标是确定出院后接受抗生素干预的患者频率以及抗生素相关药物不良反应(ADR)。这项回顾性研究评估了2015年10月1日至2015年11月24日期间在急诊科送检尿培养的患者。排除留置导尿管、同时使用抗生素以及因住院治疗而入院的患者。在SAS中应用检验和列联表;P < 0.05被认为具有统计学意义。在急诊科采集尿培养的429例不同患者中,13.1%(n = 56)接受了菌尿症治疗。在急诊科出院时接受抗生素治疗的大多数患者在病历中有尿路感染(UTI)症状记录(76.8%;n = 43)。在那些需要出院后干预的患者中,13例中有4例根据随访时的培养和药敏结果进行了适当的抗生素调整。在一部分尿培养医嘱不合理(无UTI症状记录或未开具抗生素)的患者中,与尿常规(UA)异常的患者相比,尿常规正常的患者比例更高(83.3%对10.4%,P = 0.00